Insights
The Opioid Crisis in the US: Fueling the Next Wave of Drug Development for Chronic Pain
While the opioid crisis may be creating opportunity for development of novel therapies to treat chronic pain, drug development in this area has historically struggled. According to a BIO report released in 2018, only two novel NCEs were approved for pain indications from 2007-2017 while other analgesia approvals during this period were reformulations of existing compounds or drugs with approval history prior to 2007.
Read MoreTools4Patient: Starting a new year with 20/20 hindsight
As 2019 came to a close and we begin a new decade, it’s an excellent opportunity to evaluate and learn from the past year and set a course for the future. Tools4Patient (T4P) had a momentous year as we increased on our focus on the commercialization of Placebell©™ – T4P’s innovative approach to reduce the impact of the
Read MoreIs the placebo effect contagious between investigators and patients?
A recent study published in Nature Human Behavior developed a methodology to understand and assess the role of physician expectation on the placebo response. Read more about this study here.
Read MoreTools4Patient Introduces New Brand and Website
Tools4Patient is committed to our mission of developing predictive tools to optimize the evaluation of clinical-stage drugs. Along with our recent launch of Placebell©™ – a predictive algorithm focused on the placebo response – and our recent fundraising to support commercialization of Placebell©™ and further R&D, T4P is entering a new phase as a company.
Read MoreThe Case Against Excluding High Placebo Responders from Clinical Trials
Drug developers have been struggling with the placebo response for decades, as a strong placebo effect diminishes the ability to distinguish pharmacologic treatment efficacy of an experimental drug.
Read MorePatient-Centricity at the Heart of Innovation
Tools4Patient was founded with the goal of developing innovative, sophisticated tools to optimize clinical trial design and data analysis, with the ultimate objective of providing safer and more efficacious treatments for patients.
Read More